SciBase presents the next generation Nevisense and a new type of electrode for the evaluation of New Applications
SciBase presents a new generation of its Nevisense device for early detection of malignant melanoma. The new Nevisense includes improvements in both software and hardware with the aim of streamlining the EIS measurement process. In addition, SciBase presents software and a new type of electrode which transform Nevisense into an impedance measurement platform for the evaluation of new clinical indications such as non-melanoma skin cancer.The new Nevisense contains a number of new features aimed at improving the user experience and better integrating Nevisense into daily clinical workflow.